145 related articles for article (PubMed ID: 8106650)
1. A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression.
Tignol J
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):18S-22S. PubMed ID: 8106650
[TBL] [Abstract][Full Text] [Related]
2. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients.
De Wilde J; Spiers R; Mertens C; Bartholomé F; Schotte G; Leyman S
Acta Psychiatr Scand; 1993 Feb; 87(2):141-5. PubMed ID: 8447241
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
Geretsegger C; Böhmer F; Ludwig M
Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.
Schöne W; Ludwig M
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):34S-39S. PubMed ID: 8106654
[TBL] [Abstract][Full Text] [Related]
6. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
7. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
[TBL] [Abstract][Full Text] [Related]
8. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
Fava M; Amsterdam JD; Deltito JA; Salzman C; Schwaller M; Dunner DL
Ann Clin Psychiatry; 1998 Dec; 10(4):145-50. PubMed ID: 9988054
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
Besançon G; Cousin R; Guitton B; Lavergne F
Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
[TBL] [Abstract][Full Text] [Related]
13. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
14. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Waintraub L; Septien L; Azoulay P
CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
Judge R; Parry MG; Quail D; Jacobson JG
Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period.
Kreider MS; Bushnell WD; Oakes R; Wheadon DE
J Clin Psychiatry; 1995 Apr; 56(4):142-5. PubMed ID: 7713852
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
20. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Fava M; Hoog SL; Judge RA; Kopp JB; Nilsson ME; Gonzales JS
J Clin Psychopharmacol; 2002 Apr; 22(2):137-47. PubMed ID: 11910258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
